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Abstract
Background: TCR and CXCR4-mediated signaling appears to be reciprocally regulated pathways.
TCR activation dampens the chemotactic response towards the CXCR4 ligand CXCL12, while T
cells exposed to CXCL12 are less prone to subsequent TCR-activation. The heterotrimeric G
proteins Gαq and Gαi2 have been implicated in CXCR4-signaling and we have recently also reported
the possible involvement of Gαq in TCR-dependent activation of Lck (Ngai et al., Eur. J. Immunol.,
2008, 38: 32083218). Here we examined the role of Gαq in migration and TCR activation.
Results: Pre-treatment of T cells with CXCL12 led to significantly reduced Lck Y394
phosphorylation upon TCR triggering indicating heterologous desensitization. We show that
knockdown of Gαq significantly enhanced basal migration in T cells and reduced CXCL12-induced
SHP-1 phosphorylation whereas Gαi2 knockdown inhibited CXCL12-induced migration.
Conclusion: Our data suggest that Gαi2 confers migration signals in the presence of CXCL12
whereas Gαq exerts a tonic inhibition on both basal and stimulated migrational responses. This is
compatible with the notion that the level of Gαq activation contributes to determining the
commitment of the T cell either to migration or activation through the TCR.
Background
Chemokines dictate the migration and positioning of leu-
kocytes at steady-state and in inflammation [1]. The
chemokine CXCL12, also known as stromal cell-derived
factor-1α (SDF-1α), is a member of the CXC chemokine
subfamily and serves as the only known ligand for the
chemokine receptor CXCR4 expressed on most leukocytes
[1-3]. Mice lacking CXCL12 or CXCR4 die perinatally of
cardiovascular, neurologic, vascular, and hematopoietic
defects [4,5]
The CXCR4 receptor is a G-protein coupled receptor
(GPCR) and couples to heterotrimeric G-proteins of both
the Gαi and Gαq-families [6-8]. Members of the Gαi-family
of G-proteins are pertussis toxin sensitive and pre-treat-
ment of cells with pertussis toxin severely attenuates
chemotaxis in response to chemokines. Gαi-proteins are
therefore thought to be essential for chemokine-mediated
migration. Of the Gαi-family, Gαi2 and Gαi3 are strongly
expressed by lymphocytes [9]. Gαi3-/- mice are without
phenotype [10] whereas Gαi2-/- mice display dysfunctional
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to chemokines [6]. In contrast, Gαq has been shown to be
required for chemotaxis of dendritic cells and granulo-
cytes, but not for T cells [7].
Stimulation of the T cell receptor (TCR), the B cell recep-
tor, or the Ly49D activating receptor all reduce lym-
phocyte migration toward CXCL12 [11-14] suggesting
that cells dedicated to proliferation/differentiation are less
sensitive towards chemokines. The opposite is also true, as
cells exposed to CXCL12 show less phosphorylation of
ZAP-70 and LAT following subsequent TCR activation
indicating reciprocal regulation between CXCR4 and the
TCR [13]. In addition, recruitment of chemokine recep-
tors into the immunological synapse has been shown to
stabilize T cell-APC interaction through activation of a
Gαq-dependent pathway. This renders the cell less respon-
sive to chemotactic gradients and gives higher T cell pro-
liferative responses and cytokine production [8]. Recently,
the TCR and CXCR4 were shown to closely associate upon
CXCL12-stimulation [15], and it was suggested that
CXCR4 signaling occurs through the immunoreceptor
tyrosine-based activation motif (ITAM)-domain present
in the CD3ζ chain. Collectively, these results point to a
direct crosstalk between the signaling machineries utilized
by the TCR and CXCR4.
We have recently shown that Gαq knockdown in T cells
inhibits the activation of the Src family kinase Lck [16].
The effect of Gαq on Lck activation might be conferred by
a direct interaction and/or by affecting the threshold for
TCR-triggering. We demonstrate here that knockdown of
Gαq significantly enhances basal T cell migration while
inhibiting TCR-induced Lck activation. Pre-treating cells
with CXCL12 prior to stimulation with anti-CD3 leads to
a similar inhibition of Lck activation indicating that cells
directed to migrate are less responsive to TCR triggering.
The signals conveyed by Gαq appear to be mediated
through a SHP-1 pathway. Our data suggest that optimal
TCR activation requires signaling through Gαq, and that
removal of Gαq locks the cell in migration modus making
the cell less responsive to TCR signaling
Methods
Antibodies and reagents
Human recombinant CXCL12 was obtained from Invitro-
gen (cat. no. PHC1344) and Peprotech (Rocky Hill, NJ).
Antibody to Gαi2 was from Calbiochem (cat. no. 371727).
Antibodies against SH-PTP1, Gαq, Lck, Protein A/G Plus
Agarose beads and SH-PTP1 conjugated agarose beads
were purchased from Santa Cruz (cat. no. sc-287, cat. no.
sc-393, cat. no. sc-433, cat. no. sc-2003, cat. no. sc-287
AC). Antibodies against phospho-p44/42 MAPK (Thr202/
Tyr204) and Src pY416 (detecting also Lck pY394) were
obtained from Cell Signaling (cat. no. 9106 and cat. no.
2101). Anti-phosphotyrosine mAb (4G10) was purchased
from Upstate (cat. no. 05-777). Peroxidase-conjugated
secondary antibodies and Affinipure F(ab')2 fragment
Goat Anti-Mouse IgG were obtained from Jackson Immu-
noResearch Laboratories (cat. no. 111-035-144, cat. no.
115-035-146, cat. no. 115-006-072). Anti-CXCR4-PE was
obtained from BD Pharmingen (cat. no. 555974).
siRNA design
21-nt siRNA duplexes targeting human Gαq mRNA
(NM_002072) (GNAQ-1103; 5'-GGAGUACAAUCUG-
GUCUAAUU-3'; 5'-UUAGACCAGAUUGUACUCCUU-3')
and a triple G/C switch control (GNAQ-1103M3; 5'-GCA-
GUAGAAUCUGCUCUAAUU-3'; 5'-UUACACCACAUU-
GUAGUCCUU-3'); Gαi2 mRNA (NM_002070.1) (GNAI-
1050; 5'-GGACCUGAAUAAGCGCAAAGA-3'; 5'-
UUUGCGCUUAUUCAGGUCCUC-3') were designed and
synthesized in-house. The oligos are named according to
the position of the 5' nucleotide of the sense strand rela-
tive to the reference sequences. For a detailed characteriza-
tion of the effect of these siRNAs, see Ngai et al. [16].
Cell culture and transfections
The Jurkat TAg T cell line stably transfected with SV40
large T antigen was kept in logarithmic growth in RPMI-
1640 (Invitrogen) supplemented with 10% FCS, 1% Pen-
icillin-Streptomycin, 1% Non-essential amino acids and
1% Sodium Pyruvate. 20 × 106 cells were washed and
resuspended in 400 μl OptiMEM (Invitrogen), mixed with
cDNA or siRNA and electroporated in 0.4 cm electropora-
tion cuvettes (Bio-Rad) at 250 V/cm and 975 μF. Cells
were harvested 48 hours post transfection.
Cell stimulation and lysis
Cells were resuspended in RPMI 1640 to 50 × 106/ml and
pre-incubated at 37°C for 5 minutes. Cells were then
stimulated with 100 ng/ml CXCL12 or 1.5 μg/ml OKT3
for the indicated time points and the reaction was subse-
quently stopped by lysis in ice cold lysis buffer (50 mM
HEPES, 100 mM NaCl, 5 mM EDTA, 50 mM NaF, 10 mM
Na-pyrophosphate, 1 mM Na3VO4, 1 mM PMSF, 1.0%
Triton X-100). Where indicated, cells were pre-treated
with 100 ng/ml CXCL12 or 10 μM PP2 for 30 minutes at
37°C prior to stimulation. Samples were spun down at 13
000 rpm for 10 min and the supernatant boiled with SDS-
buffer, subjected to SDS-PAGE and transfered to PVDF fil-
ters. Filters were subjected to immunoblotting with the
indicated antibody over night at 4°C, washed 3 × 10 min-
utes with TBS-T, incubated 45 minutes with secondary
antibody at RT, washed 3 × 10 minutes with TBS-T before
incubation with SuperSignal West Pico Chemilumines-
cent Substrate for 5 minutes.Page 2 of 9
(page number not for citation purposes)
BMC Immunology 2009, 10:27 http://www.biomedcentral.com/1471-2172/10/27Intracellular Ca2+ measurement
Cells were resuspended to 107 cells/ml in PBS w/1% BSA
and incubated with 4 μg/ml Fluo-4 AM and 10 μg/ml Fura
Red AM for 30 minutes at 30°C. Cells were spun down
and resuspended to 3 × 107 cells/ml in PBS w/1% BSA.
Cells were stimulated with 100 ng/ml CXCL12 and Ca2+
levels were measured by flow cytometry.
Migration assay
Migration assays were performed in 24-well plates with
5.0 μm pore-sized polycarbonate membrane inserts (Cos-
tar Transwell, Cat. no. CLS-3421). Cells were washed in
RPMI-1640 supplemented with 2% FCS and 25 mM
Hepes (chemotaxis medium) and resuspended to 1 × 106
cells/ml. Six hundred μl chemotaxis medium was added
to wells with or without 10 ng/ml CXCL12. Cells (1.5 ×
105) were loaded into the transwell inserts and allowed to
migrate for 2 hrs at 37°C and 5% CO2. Cells that had
passed through the filter into the lower chamber were col-
lected and 10 μl of an internal bead control (Bangs Labo-
ratories, Fishers, IN) was added. The cells were counted by
flow cytometry (FACS Calibur, Becton Dickinson) and
normalized with reference to the internal bead control.
Migration index was calculated as the number of cells
migrating towards CXCL12 in the test well relative to the
number of unmanipulated cells migrating towards
medium in the control wells.
CXCR4 surface expression
Forty-eight hours post-transfection, Jurkat T cells were
stimulated with 100 ng/ml CXCL12 for different time
points, washed in ice-cold PBS, fixed in 4% paraformal-
dahyde for 10 minutes at 37°C, washed in PBS, and resus-
pended in PBS w/1% BSA and anti-CXCR4-PE for 30 min
at 4°C. Thereafter the cells were washed in PBS w/1% BSA
and subjected to flow cytometric analysis for detection of
surface CXCR4 expression.
Statistical analysis
All data are representative of at least three different exper-
iments. Values are expressed as mean ± S.E.M as indicated
in the figures. Statistical analysis was performed with Stu-
dent's t-test.
Results and Discussion
CXCL12-pretreatment attenuates TCR-induced Lck 
activation comparable to the Gαq-kd-kd phenotype
We have previously shown that siRNA-mediated knock-
down of the heterotrimeric G protein Gαq in T cells atten-
uates TCR-induced Lck activation [16]. While the TCR is
not thought to be directly associated with G proteins, the
chemokine receptor CXCR4 can couple to both Gαq and
Gαi2. Furthermore, CXCR4 has been shown to associate
with TCR upon CXCL12 activation [15]. Activation of
tyrosine kinases by Gα-subunits has been demonstrated
[17-20] and could represent the mechanism by which
CXCR4 activates Lck [21]. We show here that the Src fam-
ily kinase inhibitor, PP2, abrogated CXCL12-induced
tyrosine-phosphorylation of several proteins (Figure 1A,
marked with *), a further indication that Src family
kinases act downstream of CXCR4. However, the changes
in tyrosine phosphorylation following CXCL12 treatment
are modest compared to those of anti-CD3 treatment
(data not shown). Furthermore, pre-treatment of Jurkat T
cells with CXCL12 prior to stimulation with anti-CD3
attenuated TCR-induced Lck activation (Figure 1B). Simi-
larly, we also observed reduced ZAP-70 phosphorylation
in cells pre-stimulated with CXCL12 (Figure 1B). This is in
line with a previous report showing reduced TCR-induced
phosphorylation of ZAP-70 and LAT in CXCL12-pre-
treated cells [13] suggesting that post-activation heterolo-
gous desensitization is occurring possibly as a result of
Gαq sequestration. Consistent with this notion surface
expression of CXCR4 was also down after 30 minutes
incubation with CXCL12. To address the role of Gα-subu-
nits in controlling the switch between TCR and CXCR4-
signaling events, we subjected Jurkat T cells to siRNAs
against Gαq or Gαi2. We achieved more than 90% knock-
down with these siRNAs as analysed by Western blotting
(Fig. 1C). As previously demonstrated [16] TCR-induced
Lck Y394 autophosphorylation was reduced in Gαq-
knockdown but not Gαi2-knockdown T cells demonstrat-
ing that Gαq may directly or indirectly activate Lck (Fig
1C).
Gαq-kd sets the threshold for chemotaxis
The reciprocal regulation between the TCR and chemok-
ine receptors [13,22,23] suggest that the response to a spe-
cific chemokine is determined both by the differentiation
and the activation state of the responding T cell. This
implies that migrating T cells are less responsive to activa-
tion through the TCR. The physiological relevance of this
switch between migration modus and TCR activation
modus may be to ensure that migrating T cells do not get
distracted by activation cues until they reach their destina-
tion. Conversely, TCR triggered T cells are less responsive
to chemotactic gradients to ensure optimal activation. We
observed that knockdown of Gαq enhanced basal migra-
tion 2-fold (Figure 2A), suggesting that Gαq may set the
threshold for directed migration. This supports the find-
ings of Molon et al. [8] who speculated that CXCR4 sign-
aling through Gαq promoted adhesion instead of
migration. Accordingly, we saw that knockdown of Gαi2
inhibited directed CXCL12-induced migration, while Gαq
knockdown had no effect (Figure 2A) confirming the
notion that Gαi2 is the principal Gα-subunit involved in
chemotaxis. The inhibitory effect of Gαi2 knockdown
could however be partly reversed with simultaneous
knockdown of Gαq (Figure 2A). We speculate that the pres-
ence of Gαq and absence of Gαi2 may result in a combinedPage 3 of 9
(page number not for citation purposes)
BMC Immunology 2009, 10:27 http://www.biomedcentral.com/1471-2172/10/27Figure 1 (see legend on next page)Page 4 of 9
(page number not for citation purposes)
BMC Immunology 2009, 10:27 http://www.biomedcentral.com/1471-2172/10/27strong inhibitory effect on chemotaxis. Removal of Gαq,
will then lead to partial release of the inhibitory effect of
Gαi2 knockdown alone. Although T cells from Gαq-/- mice
show no migrational defects [7], data from knockout mice
are difficult to interpret as compensatory mechanisms
may have been established during development. Acute
knockdown with siRNA provides an alternative method to
examine protein functions. How CXCR4 switches its sign-
aling through Gαi2 and Gαq is unknown, but the level of
TCR engagement has been implicated [8,13]. Surface
expression of CXCR4 following CXCL12-stimulation was
neither affected by knockdown of Gαq nor Gαi2 during a 1-
hour time course (Figure 2B, only 0 minutes and 30 min-
utes shown). The level of surface expression of CD3 on
Jurkat Tags has recently been reported [24]. Furthermore,
we suggest that neither Ca2+-elevation nor ERK1/2 phos-
phorylation are involved in chemotaxis as has been sug-
gested in a previous report [7]. While elevation of
intracellular Ca2+ was abrogated in the Gαq-knockdown
cells upon CXCR4-stimulation (Figure 2C), it was intact in
Gαi2-knockdown cells. The level of ERK1/2 phosphoryla-
tion was similar in both Gαq-knockdown and Gαi2-knock-
down Jurkat cells. However, concomitant knockdown of
both Gαq and Gαi2 completely attenuated ERK1/2 phos-
phorylation (Figure 2D), indicating that this is a G-pro-
tein dependent event.
The Gαi2-kd-signaling pathway dominates the CXCL12-
induced migrational response
To test whether the Gαi2-signaling pathway is the principal
pathway activated by CXCR4 we pre-treated cells with the
PI3K inhibitor wortmannin prior to incubation with
CXCL12. In the presence of wortmannin CXCL12-
induced migration was strongly inhibited (Figure 3A vs
Figure 2A). Furthermore, in the presence of wortmannin
the Gαq-kd cells displayed an approximately 80% increase
in CXCL12-induced migration (Figure 3A). This suggests
that the negative regulatory effect of Gαq on migration is
normally not observed when the Gαi2 signaling pathway
through PI3K is intact, and that a switch from Gαi2 to Gαq
is necessary to fully inhibit migration. These observations
correlate well with the data showing that co-knockdown
of Gαq and Gαi2 has a smaller inhibitory effect on migra-
tion than knockdown of Gαi2 alone (Figure 2A). Although
the presence of Lck is shown to be necessary for migration
[21] activating Lck through the TCR receptor has an inhib-
itory effect on migration [13]. Consistent with these find-
ings cells transfected with the constitutively active Lck
Y505F showed a significant inhibition of migration com-
pared to vector-transfected cells (Figure 3B). Interestingly,
the effect of Gαq-kd on wortmannin-treated T cells in the
presence of CXCL12 is reversed when transfected with Lck
Y505F indicating that the effect of Gαq is mediated
through Lck (Figure 3C).
Gαq-kd inhibits migration through activation of SHP-1
Src homology phosphatase-1 (SHP-1) is an Lck-activated
tyrosine phosphatase reported to negatively regulate
CXCL12-induced migration [25]. As we have recently
reported that Gαq may activate Lck we examined how Gαq
manipulation would affect SHP-1 regulation in migra-
tion. Knockdown of Gαq resulted in decreased tyrosine
phosphorylation of SHP-1 compared to control cells (Fig
4A and 4B). This may indicate a role for Gαq in the activa-
tion of SHP-1. Interestingly, increased basal phosphoryla-
tion of SHP-1 was observed in Gαi2 knockdown cells. This
may be due to skewing of the CXCR4 signaling pathway
towards Gαq as there is less Gαi2 available. Conversely,
knockdown of Gαq might skew the CXCR4 signaling path-
way towards Gαi2. To assess the role of SHP-1 in chemo-
taxis we transfected Jurkat T cells with the phosphatase-
deficient, mutant SHP-1 C453S (c/s) that competes with
endogenous SHP-1. Cells transfected with the mutant
showed significantly increased basal and CXCL12
induced migration compared to control cells indicating
that an Lck-Gαq-SHP-1 pathway may regulate migration
(Fig 4C). Migration is probably not exclusively regulated
by SHP-1 and other negative regulators of migration acti-
vated by Gαq-kd might exist.
Conclusion
We have previously shown that knockdown of Gαq atten-
uates TCR-induced Lck activation by an unknown mecha-
nism [16]. While Gαi2 has a positive role in inducing
(A) Jurkat TAg T cells were incubated with or without 10 μM PP2 for 30 minutes at 37°C prior to stimulation with CXCL12 100 ng/ml) for the indicat d time-points and stopped with lysis bu feFigure 1 (see previous p g )
CXCL12-pretreatment attenuates TCR-induced Lck activation. (A) Jurkat TAg T cells were incubated with or with-
out 10 μM PP2 for 30 minutes at 37°C prior to stimulation with CXCL12 (100 ng/ml) for the indicated time-points and 
stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. (B) Jurkat TAg T cells 
were incubated with 100 ng/ml CXCL12 for 30 minutes at 37°C prior to stimulation with OKT3 (1.5 μg/ml) for the indicated 
time-points and stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. Cells 
were also stained with anti-CXCR4 and surface expression of the receptor was analysed by flow cytometry. (C) Jurkat TAg T 
cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA 
(GNAQ1103 M3). 48 hours post-transfection cells were stimulated with OKT3 (1.5 μg/ml) for the indicated time-points and 
stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. All figures are repre-
sentative of at least 3 independent experiments.Page 5 of 9
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moting Lck activity resulting in increased SHP-1 activity
(Figure 4D). Previous reports have demonstrated a recip-
rocal regulation between the TCR and chemokine-recep-
tors [13,22,23]. Based on our recent report, an optimal
TCR-triggering may require the Gαq signaling pathway as
Gαq knockdown attenuates TCR-induced Lck activation
[16]. In contrast, Gαq knockdown appears to release
migration from tonic inhibition. This is in line with data
showing increased proliferation and cytokine-production
when chemokine-receptors signal through Gαq [8] sug-
gesting that a switch from Gαi2 to Gαq through the chem-
okine-receptor promotes T cell activation rather than
migration. In conclusion, we suggest that Gαq activation
strengthens the commitment of T cells to activation
through the TCR while Gαi2 activation commits the T cell
to migration. This might contribute to ensure that T cells
migrating towards a site of infection do not get distracted
by unnecessary activation cues, while activated T cells are
fully committed towards differentiation and proliferation.
(A) Jurkat TAg T cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GN Q1103 M3)Figure 2 (see previous pag )
Gαq and Gαi2 have opposing roles in chemotaxis. (A) Jurkat TAg T cells were transfected with Gαq-specific siRNA 
(GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were 
placed in Costar Transwell wells with/without 10 ng/ml CXCL12. After 2 hours incubation the numbers of migrated cells were 
counted by flow cytometry Migration index was calculated as the number of cells migrating divided by the number of basal 
migrating mock tx cells (n = 8). (B) Cells were subjected to transfection as in (A). 48 hours post-transfection cells were stimu-
lated with CXCL12 for the indicated time points. Cells were stained with anti-CXCR4 and surface expression of the receptor 
was analysed by flow cytometry (n = 3). (C) Cells were subjected to transfection as in (A). 48 hours post-transfection cells 
were stained with Fluo-4 and Fura Red AM and calcium fluxes were measured by flow cytometry. Grey lines indicates CXCL12 
stimulated cells, black line unstimulated cells. Representative of 3 independent experiments. (D) Cells were subjected to trans-
fection as in (A). 48 hours post-transfection cells were stimulated with CXCL12 for the indicated time points, lysed and sub-
jected to immunoblot analysis with the indicated antibodies. Levels of immunoreactive protein were quantified by 
densitometric scanning from 3 independent experiments and normalized against total protein (Mean ± S.E.M.).
CXCL12 stimulation primarily activates Gαi2. (A) Jurkat TAg T cells were tranfected with G-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3)Figure 3
CXCL12 stimulation primarily activates Gαi2. (A) Jurkat TAg T cells were tranfected with G-specific siRNA 
(GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were 
pre-treated with Wortmannin for 30 minutes and analyzed for CXCL12 dependent and independent migratory responses. 
Migration index represents fold migration over basal in control cell wells. (B) Jurkat TAg T cells were transfected with Lck 
Y505F or empty vector migration was analysed in the absence and presence of CXCL12 (10 ng/ml). Migration index represents 
fold increase in migration over basal migration in wells with control cells. (C) Cells were subjected to tranfection as in (B) pre-
treated with Wortmannin as in (A) and migration with CXCL12 was analysed. Migration index represents fold increase in 
migration over basal migration in wells with control cells.Page 7 of 9
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(A) Jurkat TAg T cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GN Q1103 M3)Figure 4
Migration is inhibited by activation of SHP-1. (A) Jurkat TAg T cells were transfected with Gαq-specific siRNA 
(GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were 
stimulated with CXCL12 for the indicated time periods and lysed in lysis buffer. SHP-1 immunoprecipitation was performed 
and immune complexes analysed by immunobloting with the indicated antibodies (n = 3). (B) Immunoblots from 3 independent 
experiments like in (A) were quantified by densiometric analysis. The graph show mean ± S.E.M. (C) Jurkat TAg T cells were 
tranfected with the phosphatase defective SHP-1 c/s (C453S) mutant or empty vector. 24 hours post-transfection cells were 
placed in Costar Transwell plates with or without CXCL12 (10 ng/ml) and migration analysed as above. Migration index repre-
sents fold increase in migration over basal migration in wells with vector tx cells (n = 3). (D) Activation of Gαi2 induces migra-
tion through a PI3K pathway whereas activation of Gαq inhibits migration through an Lck-SHP-1 pathway priming cell for 
activation through the TCR.
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